Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Other Working Capital Changes came in at -$4.9 million in Q4 2025, down 174.08% year-on-year from $6.6 million in Q4 2024, and down 691.23% quarter-over-quarter from $821000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$4.9 million for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 174.08% year-over-year to -$4.9 million in Q4 2025; TTM through Dec 2025 was $7.8 million, a 15225.49% increase from a year earlier, with the FY2025 full-year figure at -$4.7 million, down 156.67% from the prior year.
- Other Working Capital Changes improved to $24000.0 in Q4 2024 per PBH's latest filing, from $20000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.1 million in Q4 2020 and bottomed at $2000.0 in Q2 2022.
- The 5-year median for Other Working Capital Changes is $43000.0 (2021), against an average of $390000.0.
- Across the five-year window, Other Working Capital Changes soared 687.75% in 2021 and tumbled 495.41% in 2022, its largest moves.
- Year by year, Other Working Capital Changes stood at $3.1 million in 2020, then slumped by 98.6% to $43000.0 in 2021, then tumbled by 86.05% to $6000.0 in 2022, then surged by 7366.67% to $448000.0 in 2023, then plunged by 94.64% to $24000.0 in 2024.
- Per Business Quant, the three latest PBH Other Working Capital Changes figures stand at $24000.0 (Q4 2024), $20000.0 (Q3 2024), and $944000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Jun 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 903,000.00 |
| Mar 31, 2025 | 903,000.00 |
| Mar 31, 2025 | 903,000.00 |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |